Description

English name: Bupivacaine hydrochloride
English Name: 1-Butyl-N- (2, 6-dimethylphenyl) -2-piperidinecarboxamide; 1-Butyl-N- (2, 6-dimethylphenyl) -2-piperidinecarboxamide hydrochloride; Bupivocoine HCl; 1-butyl-N- (2, 6-dimethylphenyl) piperidine-2-carboxamide hydrochloride (1: 1); 1-butyl-N- (2, 6-dimethylphenyl) piperidine-2-carboxamide hydrochloride; Bupivacaine HCl; 2-Piperidinecarboxamide,
1-butyl-N - (2, 6-dimethylphenyl) -, monohydrochloride; 2 ', 6'-Pipecoloxylidide, 1-butyl-, hydrochloride (6CI); Marcaina; BUPIVACAINE HYDROCHLORIDE ANHYDROUS
CAS: 14252-80-3
EINECS number: 241-917-8
Molecular formula: C18H31ClN2O2
Molecular Weight: 342.9039
Boiling point: 423.4 ° C at 760 mmHg
Flash Point: 209.9 ° C
Vapor Pressure: 2.24E-07mmHg at 25 ° C
Product use: After local anesthesia for surgery and postoperative analgesia

Description:

Anesthesia, local- Proparacaine and tetracaine are indicated to produce local anesthesia of short duration for ophthalmic procedures including measurement of intraocular pressure, removal of foreign bodies and sutures, and conjunctival and corneal scraping in diagnosis and gonioscopy.

Applications:

Proparacaine hydrochloride and tetracaine are also indicated to produce local anesthesia prior to

surgical procedures such as cataract extraction and pterygium excision, usually as an adjunct to locally injected anesthetics. Ophthalmic solutions used for intraocular procedures should be preservative-free.

Preservatives may cause damage to the corneal epithelium if a significant quantity of solutionenters the eye through the incision.